Balevic, Stephen J.
Smith, P. Brian
Testoni, Daniela
Wu, Huali
Brouwer, Kim L. R.
Zimmerman, Kanecia O.
Rivera-Chaparro, Nazario D.
Benjamin, Daniel K. Jr.
Cohen-Wolkowiez, Michael
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (2T32GM086330-06, 1K23HD060040-04, K23 HD091398-01, 2T32GM086330-06)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM122576)
Article History
Received: 27 November 2018
Revised: 12 February 2019
Accepted: 15 February 2019
First Online: 3 April 2019
Compliance with ethical standards
:
: SJB received salary and/or research support from the National Institutes of Health (2T32GM086330-06, 5R01-HD076676-04, HHSN275201000003I, HHSN275201800003I, 5U24-TR001608-03), the Rheumatology Research Foundation’s Scientist Development Award, and the Thrasher Research Fund. The National Institutes of Health sponsor open access. PBS receives support from industry (ExternalRef removed). HW receives salary support for research from the National Institutes of Health Clinical and Translational Science Award (5UL1TR001117-05). KLRB receives funding from NIGMS, R35 GM122576. KOZ receives support for research from the National Institute for Child Health and Human Development (NICHD) (HHSN275201000003I and K23HD091398) and the Duke Clinical and Translational Science Awards (KL2TR001115). NDR-C received funding from training grant T32 from the National Institute of Child Health and Human Development (T32GM086330-06). DKBJr receives support from the National Institutes of Health (award 2K24HD058735-10, National Institute of Child Health and Human Development (HHSN275201000003I), National Institute of Allergy and Infectious Diseases (HHSN272201500006I), ECHO Program (1U2COD023375-02), and the National Center for Advancing Translational Sciences (1U24TR001608-03); he also receives research support from Cempra Pharmaceuticals (subaward to HHSO100201300009C) and industry for neonatal and pediatric drug development (ExternalRef removed). MC-W receives support for research from the NIH (5R01-HD076676, HHSN275201000003I), NIAID/NIH (HHSN272201500006I), FDA (1U18-FD006298), the Biomedical Advanced Research and Development Authority (HHSO1201300009C), and from the industry for the drug development in adults and children (ExternalRef removed). The remaining author declare that he has no conflict of interest.